Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – Rapid adoption of biodegradable films in food packaging applications is fueling market...
-
JUPITER, FL, May 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), a multi-technology biomedical company focused on the accelerated...
-
New York, May 09, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the Early Toxicity Testing Market generated USD 8.92 billion in 2022, and is projected to...
-
BANGOR, MAINE, May 09, 2023 (GLOBE NEWSWIRE) -- Becker’s Hospital Review, recently published an article called, “Top 20 pharmacy schools by NAPLEX pass rates.”[1] The article ranks college and...
-
Oral and Poster Presentations on OraGrowtH Trials at PES 2023 Further Support Potential for LUM-201 as First Oral Treatment for Moderate Idiopathic PGHD OraGrowtH212 Interim Data Demonstrate LUM-201...
-
HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...
-
Farmington, May 04, 2023 (GLOBE NEWSWIRE) -- The Global 3D Printing Material Market size was valued at USD 2.59 billion in 2022 and is projected to reach USD 12.7 billion by 2030, growing at a CAGR...
-
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 04, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “The Company”), a leading provider of innovative technologies that...
-
Austin, TX, USA, May 03, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Video Streaming Software Market Size, Trends and Insights By Component...
-
-- Patient Enrollment Completed in both Phase 2 OraGrowtH Trials ---- Primary Outcome Data for both OraGrowtH Trials Expected 4Q 2023 ---- Interim Data from OraGrowtH Trials Accepted for Presentation...